Is Ketamine a Horse Tranquilizer?
March 11, 2022
Ketamine research has transformed our understanding of mental health treatment, offering rapid relief for conditions like PTSD, depression, anxiety, OCD, chronic pain, and suicidality. As an anesthetic with a long-standing history, ketamine is now being re-examined for its therapeutic potential in mental health.
The latest research highlights ketamine’s remarkable potential to address complex mental health and pain conditions in ways that traditional treatments often cannot. These promising findings offer hope and reassurance for individuals struggling with chronic conditions, pointing to a future where relief may be more accessible and effective.
Posttraumatic stress disorder (PTSD) is a mental health condition that develops after experiencing or witnessing a traumatic event, leading to intrusive memories, nightmares, and heightened anxiety. PTSD can become Complex (CPTSD) when the trauma is chronic, unresolved, and especially when the trauma is caused by the actions or inactions of a caretaker.
For sufferers, PTSD can make daily life overwhelming and lead to emotional isolation, while loved ones often struggle with how to provide support and cope with unpredictable emotional outbursts.
A study of KAP for trauma-exposed patients explored the efficacy of KAP in treating treatment-resistant PTSD. Researchers found that ketamine, paired with psychotherapy, enhanced patients' ability to process trauma, leading to significant symptom relief. This combination approach could redefine how PTSD is treated for those who have not found success with conventional treatments.
Another study examined the use of prehospital ketamine administration in military settings to determine its impact on PTSD development. Published in Military Medicine, the findings suggest that early intervention with ketamine during traumatic events could reduce the likelihood of developing PTSD later on. This preventive use of ketamine holds promise for those exposed to high-risk, high-trauma environments.
Additionally, research into adolescents with PTSD showed that ketamine treatment reduced symptoms significantly. Published in The American Journal of Psychiatry, this study highlights ketamine's potential as an early intervention for teens, who are particularly vulnerable to long-term effects of trauma.
Depression is a common but serious mood disorder that causes persistent feelings of sadness, loss of interest, and hopelessness, often interfering with daily functioning.
People with depression may struggle to work, maintain relationships, or care for themselves, while their loved ones often feel helpless, watching the person they care about withdraw and suffer in silence.
For individuals with treatment-resistant depression (TRD), ketamine offers a breakthrough in mental health care. Unlike traditional antidepressants, which can take weeks to show effects, ketamine acts within hours.
One groundbreaking study, published in JAMA Network Open, compared ketamine to electroconvulsive therapy (ECT), a treatment for TRD that uses electrical stimulation to trigger brain activity and improve mood. Both treatments proved equally effective, but ketamine's minimal side effects made it a more appealing option for many patients.
Similarly, a meta-analysis in General Hospital Psychiatry highlighted ketamine’s rapid antidepressant effects. While long-term benefits require further exploration, the immediate reduction in depressive symptoms provides hope for those in crisis.
More ketamine research studied the impact of KAP after 3 and 6-month periods., evaluating its efficacy in treating depression, generalized anxiety disorder (GAD), and PTSD. Patients undergoing ketamine-assisted psychotherapy reported significant symptom improvements across all three conditions at the studied intervals.
Anxiety disorders are characterized by excessive fear and worry, often accompanied by physical symptoms like a racing heart, sweating, and difficulty concentrating.
People who experience chronic anxiety often lack peace, productivity, and sleep in their lives, while their loved ones may feel drained by trying to provide reassurance or adapting their shared environment to avoid their loved one’s triggering anxiety.
Anxiety disorders, especially those resistant to standard treatments, can be debilitating. Ketamine offers a new avenue for relief, with research consistently demonstrating its rapid beneficial effects.
A meta-analysis published in Therapeutic Advances in Psychopharmacology examined the use of ketamine for anxiety. Patients reported substantial symptom reductions within hours of treatment, and symptom improvement was sustained with follow-up ketamine treatment. This underscores ketamine's value for individuals seeking both urgent relief and long-term change.
Furthermore, investigation has been made into heart rate variability (HRV) as a potential biomarker for ketamine’s effectiveness in treating anxiety disorders. HRV measures variations in the time interval between heartbeats, providing insight into the body's autonomic nervous system. It reflects the balance between the sympathetic and parasympathetic systems, which is often disrupted in anxiety disorders. The findings in this study suggest that HRV could play a critical role in guiding personalized treatment approaches, helping identify patients who may benefit most from ketamine therapy.
Obsessive-compulsive disorder (OCD) is characterized by intrusive thoughts (obsessions) and repetitive behaviors (compulsions) performed to reduce anxiety.
People living with OCD often feel trapped in cycles of obsessive thoughts and compulsive actions, while their loved ones may experience frustration and helplessness as they watch someone they care about lose control of daily life.
Obsessive-compulsive disorder (OCD) often resists traditional treatment, leaving many patients in need of alternative options. Ketamine's unique mechanism of action has shown promise in alleviating OCD symptoms.
One 2024 study demonstrated that outpatient ketamine treatments provided a significant reduction in scores on the Yale-Brown Obsessive-Compulsive Scale.
Further research indicates that the chemical pathways affected by ketamine provide a positive enhancing effect on exposure and response prevention psychotherapy (ERP), one of the most powerful treatments available for OCD.
Chronic pain is a long-term condition that persists beyond the normal healing time, often caused by nerve damage or underlying conditions like arthritis or complex regional pain syndrome (CRPS).
Chronic pain limits mobility, disrupts sleep, and affects emotional health. Meanwhile, loved ones may feel strained emotionally and physically as they provide care or adapt to the sufferer’s limitations.
Chronic pain, particularly conditions like CRPS, can drastically impact quality of life. Ketamine has emerged as a valuable tool for managing these cases.
Research on ketamine for CRPS found that it provided significant pain relief when other treatments failed. This study highlights ketamine’s role as a last-resort option for chronic pain sufferers. Read the study here.
Suicidality refers to thoughts or behaviors related to ending one’s own life. Suicidality is often linked to severe depression, anxiety, or other mental health conditions.
Suicidality is an immediate crisis for sufferers, while loved ones may feel powerless, overwhelmed, and fearful as they try to prevent tragedy.
Perhaps the most life-saving aspect of ketamine research is its ability to rapidly reduce suicidal ideation. Traditional treatments can take weeks, but ketamine often works within hours.
A randomized controlled trial published in Psychological Medicine demonstrated ketamine’s significant impact on reducing suicidal thoughts. Patients with treatment-resistant depression experienced rapid relief, highlighting ketamine’s potential as a crisis intervention. Read the study here.
As ketamine research progresses, its transformative effects will likely become more accessible, offering hope to countless patients worldwide.
At Transcend Health Solutions, we are intentional about keeping current on the best pathways to healing a wide variety of mental and neurological health conditions. We stand ready to provide you with the Ketamine-Assisted Psychotherapy that can help you break free from pain into a life you’re excited to live.
For those in San Antonio and Austin, Texas, we are here to guide you on this transformative journey. Reach out to us today to find out if Ketamine-Assisted Psychotherapy is right for you.
References
Beaglehole B, Glue P, Neehoff S, et al. Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study. Journal of Psychopharmacology. 2024;0(0). https://doi.org/10.1177/02698811241301215
Davis, A. K., Mangini, P., & Xin, Y. (2021). Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting: A clinical chart review study. Journal of Psychedelic Studies, 5(2), 94-102. https://doi.org/10.1556/2054.2021.00179
Jha, M. K., Wilkinson, S. T., Krishnan, K., Collins, K. A., Sanacora, G., Murrough, J., Goes, F., Altinay, M., Aloysi, A., Asghar-Ali, A., Barnett, B., Chang, L., Costi, S., Malone, D., Nikayin, S., Nissen, S. E., Ostroff, R., Reti, I., Wolski, K., . . . Anand, A. (2024). Ketamine vs electroconvulsive therapy for treatment-resistant depression. JAMA Network Open, 7(6), e2417786. https://doi.org/10.1001/jamanetworkopen.2024.17786
Lee, E. E., Della Selva, M. P., Liu, A., & Himelhoch, S. (2015). Ketamine as a novel treatment for major depressive disorder and bipolar depression: A systematic review and quantitative meta-analysis. General Hospital Psychiatry, 37(2), 178-184. https://doi.org/10.1016/j.genhosppsych.2015.01.003
Melcer, T., Walker, G. J., Dye, J. L., Walrath, B., MacGregor, A. J., Perez, K., & Galarneau, M. R. (2022). Is prehospital ketamine associated with a change in the prognosis of ptsd? Military Medicine, 188(7-8), e2165-e2174. https://doi.org/10.1093/milmed/usac014
Murrough, J. W., Soleimani, L., DeWile, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., … Charney, D. S. (2015). Ketamine for rapid reduction of suicidal ideation: a randomized controlled trials. Psychological Medicine, 45(16), 3571-3580. https://doi.org/10.1017/50033291715001506
Parikh, T., & Walkup, J. T. (2021). The future of ketamine in the treatment of teen depression. American Journal of Psychiatry, 178(4), 288-289. https://doi.org/10.1176/appi.ajp.2020.21020172
Whittaker, E., Dadabayev, A. R., Joshi, S. A., & Glue, P. (2021). Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders. Therapeutic Advances in Psychopharmacology, 11. https://doi.org/10.1177/20451253211056743
Yermus, R., Verbora, M., Kennedy, S., McMaster, R., Kratina, S., Wolfson, E., Medrano, B., Bryson, N., Zaer, N., Bottos, J., Setlur, V., & Lo, C. (2023). Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months: Findings from a large single-arm retrospective effectiveness trial. Psychedelic Medicine. https://doi.org/10.1101/2023.01.11.23284248
.svg)